Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

Shuqin Zhang,Xiangyang Yun,Qian Zheng,Guangxiao Yang,Guangyuan He,Mingjie Chen

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2015.08.051

2015-01-01

Abstract:Objective To compare the effects of Icaritin on proliferation of human hepatocellular carcinoma cell line HepG2,human lung carcinoma cell line A549 and human renal cell carcinoma cell line 786-O,and study the mechanism during those processes.Methods Methyl thiazol tetrazolium (MTT) assay was used to test the effect of Icaritin on proliferation of HepG2,A549 and 786-O cells.Apoptosis of the cells was detected by flow cytometry.The expression of several key proliferative and apoptotic related proteins was investigated by Western blotting.Results Icaritin inhibited the proliferation of HepG2,A549 and 786-O cells in a time-and dose-dependent way.The inhibition effect on 786-O cells was the highest with 44％ inhibition rate after 5 μ mol/L Icaritin treatment for 24 h and 50％ inhibitory dose (IC50) was 5.85 μmol/L.Icaritin induced apoptosis in all the three cell lines with the highest effect on 786-O cells with the apoptosis rate being 45.8％.Icaritin reduced the expression of Cyclin A,Cyclin D1,Cyclin E,cyclin dependent kinase 2 (CDK2) and B cell lymphoma/leukemia-2 (bcl-2).The up-regulated protein expression of bcl-2 associated X protein (bax) was also observed.Conclusion Icaritin inhibited proliferation of HepG2,A549 and 786-O cells and induced apoptosis significantly.The effect on 786-O cells was the highest.This process may be involved in the regulation of several Cyclins,bcl-2-associated X protein (bax) and bcl-2.